Nanoparticulate Drug Delivery Systems

Nanoparticles (NPs) occur naturally and have been in existence for thousands of years as products of combustion and cooking of food. Nanomaterials differ significantly from other materials due to the following two major principal factors: the increased surface area and quantum effects. These factors can enhance properties such as reactivity, strength, electrical characteristics, and in vivo behaviour. As the particle size decreases, a greater proportion of atoms are found at the surface compared to inside. An NP has a much greater surface area per unit mass compared with larger particles, leading to greater reactivity. In tandem with surface area effects, quantum effects can begin to dominate the properties of matter as size is reduced to the nanoscale. These can affect the optical, electrical, and magnetic behaviour of materials. Their in vivo behaviour can be from increased absorption to high toxicity of nanomaterials. New drug carrier systems are one can name soluble polymers, microparticles made of insoluble (or) biodegradable natural and synthetic  polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes and micelles. Pharmaceutica 2018 evolves to be a drug disintegration conference, emulsion conference, capsule conference, and solubility conference. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more. 

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, and Peptisyntha Inc. at the pharmaceutical companies’ conference.

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

  • Liposomal Drug Delivery Systems
  • Microemulsions and Nanoemulsions
  • Solid Lipid Nano and Microparticles
  • Polymers
  • Organic Nanotubes: Promising Vehicles for Drug Delivery
  • Dendrimers
  • Micelles
  • Cyclodextrins
  • Nanogels
  • Metal Nanoparticles and Quantum Dots

Related Conference of Nanoparticulate Drug Delivery Systems

October 31-01, 2024

37th World Congress on Pharmacology

Amsterdam, Netherlands
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE
February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
March 13-14, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands

Nanoparticulate Drug Delivery Systems Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in